Form 4: Grace Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
A Brian Davis, a Director of Grace Therapeutics, Inc., reported multiple transactions in common stock on September 17, 2026.
Summary
- Grant/award: acquired 0 Stock Option (Right to Buy) on September 17, 2026; holds 12,200 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
A Brian Davis — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-17 | Grant/award | Stock Option (Right to Buy) | 0 | — | — | 12,200 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-17 | Grant/award (0 shares) |
Keywords
insider transaction, Form 4, GRCE, Grace Therapeutics, Inc., neutral, A Brian Davis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.